Poisoning by, adverse effect of and underdosing of primarily systemic and hematological agents, not elsewhere classified (T45)

Browse all the diagnosis codes used for poisoning by, adverse effect of and underdosing of primarily systemic and hematological agents, not elsewhere classified (t45). For easy navigation, the diagnosis codes are sorted in alphabetical order and grouped by sections. Each section is clearly marked with its description, and the corresponding three-digit code range. This format makes it simple to browse diagnosis codes in this chapter or section and find what you're looking for. We've also added green checkmark icons to label billable codes, and red warning icons for non-billable ones. This makes it easy to identify which codes can be billed.

Clinical Information

Agranulocytosis - A decrease in the number of GRANULOCYTES; (BASOPHILS; EOSINOPHILS; and NEUTROPHILS).

Anticoagulants - Agents that prevent BLOOD CLOTTING.

Factor Xa - Activated form of factor X that participates in both the intrinsic and extrinsic pathways of blood coagulation. It catalyzes the conversion of prothrombin to thrombin in conjunction with other cofactors.

Factor Xa Inhibitors - Endogenous factors and drugs that inhibit or block the activity of FACTOR XA.

Feline Panleukopenia - A highly contagious DNA virus infection of the cat family, characterized by fever, enteritis and bone marrow changes. It is also called feline ataxia, feline agranulocytosis, feline infectious enteritis, cat fever, cat plague, and show fever. It is caused by FELINE PANLEUKOPENIA VIRUS or the closely related MINK ENTERITIS VIRUS or CANINE PARVOVIRUS.

Reticulocytosis - An increase in circulating RETICULOCYTES, which is among the simplest and most reliable signs of accelerated ERYTHROCYTE production. Reticulocytosis occurs during active BLOOD regeneration (stimulation of red bone marrow) and in certain types of ANEMIA, particularly CONGENITAL HEMOLYTIC ANEMIA.

Rheumatoid Nodule - Subcutaneous nodules seen in 20-30% of rheumatoid arthritis patients. They may arise anywhere on the body, but are most frequently found over the bony prominences. The nodules are characterized histologically by dense areas of fibrinoid necrosis with basophilic streaks and granules, surrounded by a palisade of cells, mainly fibroblasts and histiocytes.

Instructional Notations

7th Character Note

Certain ICD-10-CM categories have applicable 7th characters. The applicable 7th character is required for all codes within the category, or as the notes in the Tabular List instruct. The 7th character must always be the 7th character in the data field. If a code that requires a 7th character is not 6 characters, a placeholder X must be used to fill in the empty characters.

  • The appropriate 7th character is to be added to each code from category T45

7th Character

Indicates that a seventh character is to be assigned to codes in a subcategory.

  • A - initial encounter
  • D - subsequent encounter
  • S - sequela
  • Injury, poisoning and certain other consequences of external causes (S00–T88)

    • Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances (T36-T50)

        • Poisoning by, adverse effect of and underdosing of primarily systemic and hematological agents, not elsewhere classified (T45)

        • T45 Poisoning by, adverse effect of and underdosing of primarily systemic and hematological agents, not elsewhere classified
        • T45.0 Poisoning by, adverse effect of and underdosing of antiallergic and antiemetic drugs
        • T45.0X Poisoning by, adverse effect of and underdosing of antiallergic and antiemetic drugs
        • T45.0X1 Poisoning by antiallergic and antiemetic drugs, accidental (unintentional)
        • T45.0X1A Poisoning by antiallergic and antiemetic drugs, accidental (unintentional), initial encounter
        • T45.0X1D Poisoning by antiallergic and antiemetic drugs, accidental (unintentional), subsequent encounter
        • T45.0X1S Poisoning by antiallergic and antiemetic drugs, accidental (unintentional), sequela
        • T45.0X2 Poisoning by antiallergic and antiemetic drugs, intentional self-harm
        • T45.0X2A Poisoning by antiallergic and antiemetic drugs, intentional self-harm, initial encounter
        • T45.0X2D Poisoning by antiallergic and antiemetic drugs, intentional self-harm, subsequent encounter
        • T45.0X2S Poisoning by antiallergic and antiemetic drugs, intentional self-harm, sequela
        • T45.0X3 Poisoning by antiallergic and antiemetic drugs, assault
        • T45.0X3A Poisoning by antiallergic and antiemetic drugs, assault, initial encounter
        • T45.0X3D Poisoning by antiallergic and antiemetic drugs, assault, subsequent encounter
        • T45.0X3S Poisoning by antiallergic and antiemetic drugs, assault, sequela
        • T45.0X4 Poisoning by antiallergic and antiemetic drugs, undetermined
        • T45.0X4A Poisoning by antiallergic and antiemetic drugs, undetermined, initial encounter
        • T45.0X4D Poisoning by antiallergic and antiemetic drugs, undetermined, subsequent encounter
        • T45.0X4S Poisoning by antiallergic and antiemetic drugs, undetermined, sequela
        • T45.0X5 Adverse effect of antiallergic and antiemetic drugs
        • T45.0X5A Adverse effect of antiallergic and antiemetic drugs, initial encounter
        • T45.0X5D Adverse effect of antiallergic and antiemetic drugs, subsequent encounter
        • T45.0X5S Adverse effect of antiallergic and antiemetic drugs, sequela
        • T45.0X6 Underdosing of antiallergic and antiemetic drugs
        • T45.0X6A Underdosing of antiallergic and antiemetic drugs, initial encounter
        • T45.0X6D Underdosing of antiallergic and antiemetic drugs, subsequent encounter
        • T45.0X6S Underdosing of antiallergic and antiemetic drugs, sequela
        • T45.1 Poisoning by, adverse effect of and underdosing of antineoplastic and immunosuppressive drugs
        • T45.1X Poisoning by, adverse effect of and underdosing of antineoplastic and immunosuppressive drugs
        • T45.1X1 Poisoning by antineoplastic and immunosuppressive drugs, accidental (unintentional)
        • T45.1X1A Poisoning by antineoplastic and immunosuppressive drugs, accidental (unintentional), initial encounter
        • T45.1X1D Poisoning by antineoplastic and immunosuppressive drugs, accidental (unintentional), subsequent encounter
        • T45.1X1S Poisoning by antineoplastic and immunosuppressive drugs, accidental (unintentional), sequela
        • T45.1X2 Poisoning by antineoplastic and immunosuppressive drugs, intentional self-harm
        • T45.1X2A Poisoning by antineoplastic and immunosuppressive drugs, intentional self-harm, initial encounter
        • T45.1X2D Poisoning by antineoplastic and immunosuppressive drugs, intentional self-harm, subsequent encounter
        • T45.1X2S Poisoning by antineoplastic and immunosuppressive drugs, intentional self-harm, sequela
        • T45.1X3 Poisoning by antineoplastic and immunosuppressive drugs, assault
        • T45.1X3A Poisoning by antineoplastic and immunosuppressive drugs, assault, initial encounter
        • T45.1X3D Poisoning by antineoplastic and immunosuppressive drugs, assault, subsequent encounter
        • T45.1X3S Poisoning by antineoplastic and immunosuppressive drugs, assault, sequela
        • T45.1X4 Poisoning by antineoplastic and immunosuppressive drugs, undetermined
        • T45.1X4A Poisoning by antineoplastic and immunosuppressive drugs, undetermined, initial encounter
        • T45.1X4D Poisoning by antineoplastic and immunosuppressive drugs, undetermined, subsequent encounter
        • T45.1X4S Poisoning by antineoplastic and immunosuppressive drugs, undetermined, sequela
        • T45.1X5 Adverse effect of antineoplastic and immunosuppressive drugs
        • T45.1X5A Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter
        • T45.1X5D Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter
        • T45.1X5S Adverse effect of antineoplastic and immunosuppressive drugs, sequela
        • T45.1X6 Underdosing of antineoplastic and immunosuppressive drugs
        • T45.1X6A Underdosing of antineoplastic and immunosuppressive drugs, initial encounter
        • T45.1X6D Underdosing of antineoplastic and immunosuppressive drugs, subsequent encounter
        • T45.1X6S Underdosing of antineoplastic and immunosuppressive drugs, sequela
        • T45.2 Poisoning by, adverse effect of and underdosing of vitamins
        • T45.2X Poisoning by, adverse effect of and underdosing of vitamins
        • T45.2X1 Poisoning by vitamins, accidental (unintentional)
        • T45.2X1A Poisoning by vitamins, accidental (unintentional), initial encounter
        • T45.2X1D Poisoning by vitamins, accidental (unintentional), subsequent encounter
        • T45.2X1S Poisoning by vitamins, accidental (unintentional), sequela
        • T45.2X2 Poisoning by vitamins, intentional self-harm
        • T45.2X2A Poisoning by vitamins, intentional self-harm, initial encounter
        • T45.2X2D Poisoning by vitamins, intentional self-harm, subsequent encounter
        • T45.2X2S Poisoning by vitamins, intentional self-harm, sequela
        • T45.2X3 Poisoning by vitamins, assault
        • T45.2X3A Poisoning by vitamins, assault, initial encounter
        • T45.2X3D Poisoning by vitamins, assault, subsequent encounter
        • T45.2X3S Poisoning by vitamins, assault, sequela
        • T45.2X4 Poisoning by vitamins, undetermined
        • T45.2X4A Poisoning by vitamins, undetermined, initial encounter
        • T45.2X4D Poisoning by vitamins, undetermined, subsequent encounter
        • T45.2X4S Poisoning by vitamins, undetermined, sequela
        • T45.2X5 Adverse effect of vitamins
        • T45.2X5A Adverse effect of vitamins, initial encounter
        • T45.2X5D Adverse effect of vitamins, subsequent encounter
        • T45.2X5S Adverse effect of vitamins, sequela
        • T45.2X6 Underdosing of vitamins
        • T45.2X6A Underdosing of vitamins, initial encounter
        • T45.2X6D Underdosing of vitamins, subsequent encounter
        • T45.2X6S Underdosing of vitamins, sequela
        • T45.3 Poisoning by, adverse effect of and underdosing of enzymes
        • T45.3X Poisoning by, adverse effect of and underdosing of enzymes
        • T45.3X1 Poisoning by enzymes, accidental (unintentional)
        • T45.3X1A Poisoning by enzymes, accidental (unintentional), initial encounter
        • T45.3X1D Poisoning by enzymes, accidental (unintentional), subsequent encounter
        • T45.3X1S Poisoning by enzymes, accidental (unintentional), sequela
        • T45.3X2 Poisoning by enzymes, intentional self-harm
        • T45.3X2A Poisoning by enzymes, intentional self-harm, initial encounter
        • T45.3X2D Poisoning by enzymes, intentional self-harm, subsequent encounter
        • T45.3X2S Poisoning by enzymes, intentional self-harm, sequela
        • T45.3X3 Poisoning by enzymes, assault
        • T45.3X3A Poisoning by enzymes, assault, initial encounter
        • T45.3X3D Poisoning by enzymes, assault, subsequent encounter
        • T45.3X3S Poisoning by enzymes, assault, sequela
        • T45.3X4 Poisoning by enzymes, undetermined
        • T45.3X4A Poisoning by enzymes, undetermined, initial encounter
        • T45.3X4D Poisoning by enzymes, undetermined, subsequent encounter
        • T45.3X4S Poisoning by enzymes, undetermined, sequela
        • T45.3X5 Adverse effect of enzymes
        • T45.3X5A Adverse effect of enzymes, initial encounter
        • T45.3X5D Adverse effect of enzymes, subsequent encounter
        • T45.3X5S Adverse effect of enzymes, sequela
        • T45.3X6 Underdosing of enzymes
        • T45.3X6A Underdosing of enzymes, initial encounter
        • T45.3X6D Underdosing of enzymes, subsequent encounter
        • T45.3X6S Underdosing of enzymes, sequela
        • T45.4 Poisoning by, adverse effect of and underdosing of iron and its compounds
        • T45.4X Poisoning by, adverse effect of and underdosing of iron and its compounds
        • T45.4X1 Poisoning by iron and its compounds, accidental (unintentional)
        • T45.4X1A Poisoning by iron and its compounds, accidental (unintentional), initial encounter
        • T45.4X1D Poisoning by iron and its compounds, accidental (unintentional), subsequent encounter
        • T45.4X1S Poisoning by iron and its compounds, accidental (unintentional), sequela
        • T45.4X2 Poisoning by iron and its compounds, intentional self-harm
        • T45.4X2A Poisoning by iron and its compounds, intentional self-harm, initial encounter
        • T45.4X2D Poisoning by iron and its compounds, intentional self-harm, subsequent encounter
        • T45.4X2S Poisoning by iron and its compounds, intentional self-harm, sequela
        • T45.4X3 Poisoning by iron and its compounds, assault
        • T45.4X3A Poisoning by iron and its compounds, assault, initial encounter
        • T45.4X3D Poisoning by iron and its compounds, assault, subsequent encounter
        • T45.4X3S Poisoning by iron and its compounds, assault, sequela
        • T45.4X4 Poisoning by iron and its compounds, undetermined
        • T45.4X4A Poisoning by iron and its compounds, undetermined, initial encounter
        • T45.4X4D Poisoning by iron and its compounds, undetermined, subsequent encounter
        • T45.4X4S Poisoning by iron and its compounds, undetermined, sequela
        • T45.4X5 Adverse effect of iron and its compounds
        • T45.4X5A Adverse effect of iron and its compounds, initial encounter
        • T45.4X5D Adverse effect of iron and its compounds, subsequent encounter
        • T45.4X5S Adverse effect of iron and its compounds, sequela
        • T45.4X6 Underdosing of iron and its compounds
        • T45.4X6A Underdosing of iron and its compounds, initial encounter
        • T45.4X6D Underdosing of iron and its compounds, subsequent encounter
        • T45.4X6S Underdosing of iron and its compounds, sequela
        • T45.5 Poisoning by, adverse effect of and underdosing of anticoagulants and antithrombotic drugs
        • T45.51 Poisoning by, adverse effect of and underdosing of anticoagulants
        • T45.511 Poisoning by anticoagulants, accidental (unintentional)
        • T45.511A Poisoning by anticoagulants, accidental (unintentional), initial encounter
        • T45.511D Poisoning by anticoagulants, accidental (unintentional), subsequent encounter
        • T45.511S Poisoning by anticoagulants, accidental (unintentional), sequela
        • T45.512 Poisoning by anticoagulants, intentional self-harm
        • T45.512A Poisoning by anticoagulants, intentional self-harm, initial encounter
        • T45.512D Poisoning by anticoagulants, intentional self-harm, subsequent encounter
        • T45.512S Poisoning by anticoagulants, intentional self-harm, sequela
        • T45.513 Poisoning by anticoagulants, assault
        • T45.513A Poisoning by anticoagulants, assault, initial encounter
        • T45.513D Poisoning by anticoagulants, assault, subsequent encounter
        • T45.513S Poisoning by anticoagulants, assault, sequela
        • T45.514 Poisoning by anticoagulants, undetermined
        • T45.514A Poisoning by anticoagulants, undetermined, initial encounter
        • T45.514D Poisoning by anticoagulants, undetermined, subsequent encounter
        • T45.514S Poisoning by anticoagulants, undetermined, sequela
        • T45.515 Adverse effect of anticoagulants
        • T45.515A Adverse effect of anticoagulants, initial encounter
        • T45.515D Adverse effect of anticoagulants, subsequent encounter
        • T45.515S Adverse effect of anticoagulants, sequela
        • T45.516 Underdosing of anticoagulants
        • T45.516A Underdosing of anticoagulants, initial encounter
        • T45.516D Underdosing of anticoagulants, subsequent encounter
        • T45.516S Underdosing of anticoagulants, sequela
        • T45.52 Poisoning by, adverse effect of and underdosing of antithrombotic drugs
        • T45.521 Poisoning by antithrombotic drugs, accidental (unintentional)
        • T45.521A Poisoning by antithrombotic drugs, accidental (unintentional), initial encounter
        • T45.521D Poisoning by antithrombotic drugs, accidental (unintentional), subsequent encounter
        • T45.521S Poisoning by antithrombotic drugs, accidental (unintentional), sequela
        • T45.522 Poisoning by antithrombotic drugs, intentional self-harm
        • T45.522A Poisoning by antithrombotic drugs, intentional self-harm, initial encounter
        • T45.522D Poisoning by antithrombotic drugs, intentional self-harm, subsequent encounter
        • T45.522S Poisoning by antithrombotic drugs, intentional self-harm, sequela
        • T45.523 Poisoning by antithrombotic drugs, assault
        • T45.523A Poisoning by antithrombotic drugs, assault, initial encounter
        • T45.523D Poisoning by antithrombotic drugs, assault, subsequent encounter
        • T45.523S Poisoning by antithrombotic drugs, assault, sequela
        • T45.524 Poisoning by antithrombotic drugs, undetermined
        • T45.524A Poisoning by antithrombotic drugs, undetermined, initial encounter
        • T45.524D Poisoning by antithrombotic drugs, undetermined, subsequent encounter
        • T45.524S Poisoning by antithrombotic drugs, undetermined, sequela
        • T45.525 Adverse effect of antithrombotic drugs
        • T45.525A Adverse effect of antithrombotic drugs, initial encounter
        • T45.525D Adverse effect of antithrombotic drugs, subsequent encounter
        • T45.525S Adverse effect of antithrombotic drugs, sequela
        • T45.526 Underdosing of antithrombotic drugs
        • T45.526A Underdosing of antithrombotic drugs, initial encounter
        • T45.526D Underdosing of antithrombotic drugs, subsequent encounter
        • T45.526S Underdosing of antithrombotic drugs, sequela
        • T45.6 Poisoning by, adverse effect of and underdosing of fibrinolysis-affecting drugs
        • T45.60 Poisoning by, adverse effect of and underdosing of unspecified fibrinolysis-affecting drugs
        • T45.601 Poisoning by unspecified fibrinolysis-affecting drugs, accidental (unintentional)
        • T45.601A Poisoning by unspecified fibrinolysis-affecting drugs, accidental (unintentional), initial encounter
        • T45.601D Poisoning by unspecified fibrinolysis-affecting drugs, accidental (unintentional), subsequent encounter
        • T45.601S Poisoning by unspecified fibrinolysis-affecting drugs, accidental (unintentional), sequela
        • T45.602 Poisoning by unspecified fibrinolysis-affecting drugs, intentional self-harm
        • T45.602A Poisoning by unspecified fibrinolysis-affecting drugs, intentional self-harm, initial encounter
        • T45.602D Poisoning by unspecified fibrinolysis-affecting drugs, intentional self-harm, subsequent encounter
        • T45.602S Poisoning by unspecified fibrinolysis-affecting drugs, intentional self-harm, sequela
        • T45.603 Poisoning by unspecified fibrinolysis-affecting drugs, assault
        • T45.603A Poisoning by unspecified fibrinolysis-affecting drugs, assault, initial encounter
        • T45.603D Poisoning by unspecified fibrinolysis-affecting drugs, assault, subsequent encounter
        • T45.603S Poisoning by unspecified fibrinolysis-affecting drugs, assault, sequela
        • T45.604 Poisoning by unspecified fibrinolysis-affecting drugs, undetermined
        • T45.604A Poisoning by unspecified fibrinolysis-affecting drugs, undetermined, initial encounter
        • T45.604D Poisoning by unspecified fibrinolysis-affecting drugs, undetermined, subsequent encounter
        • T45.604S Poisoning by unspecified fibrinolysis-affecting drugs, undetermined, sequela
        • T45.605 Adverse effect of unspecified fibrinolysis-affecting drugs
        • T45.605A Adverse effect of unspecified fibrinolysis-affecting drugs, initial encounter
        • T45.605D Adverse effect of unspecified fibrinolysis-affecting drugs, subsequent encounter
        • T45.605S Adverse effect of unspecified fibrinolysis-affecting drugs, sequela
        • T45.606 Underdosing of unspecified fibrinolysis-affecting drugs
        • T45.606A Underdosing of unspecified fibrinolysis-affecting drugs, initial encounter
        • T45.606D Underdosing of unspecified fibrinolysis-affecting drugs, subsequent encounter
        • T45.606S Underdosing of unspecified fibrinolysis-affecting drugs, sequela
        • T45.61 Poisoning by, adverse effect of and underdosing of thrombolytic drugs
        • T45.611 Poisoning by thrombolytic drug, accidental (unintentional)
        • T45.611A Poisoning by thrombolytic drug, accidental (unintentional), initial encounter
        • T45.611D Poisoning by thrombolytic drug, accidental (unintentional), subsequent encounter
        • T45.611S Poisoning by thrombolytic drug, accidental (unintentional), sequela
        • T45.612 Poisoning by thrombolytic drug, intentional self-harm
        • T45.612A Poisoning by thrombolytic drug, intentional self-harm, initial encounter
        • T45.612D Poisoning by thrombolytic drug, intentional self-harm, subsequent encounter
        • T45.612S Poisoning by thrombolytic drug, intentional self-harm, sequela
        • T45.613 Poisoning by thrombolytic drug, assault
        • T45.613A Poisoning by thrombolytic drug, assault, initial encounter
        • T45.613D Poisoning by thrombolytic drug, assault, subsequent encounter
        • T45.613S Poisoning by thrombolytic drug, assault, sequela
        • T45.614 Poisoning by thrombolytic drug, undetermined
        • T45.614A Poisoning by thrombolytic drug, undetermined, initial encounter
        • T45.614D Poisoning by thrombolytic drug, undetermined, subsequent encounter
        • T45.614S Poisoning by thrombolytic drug, undetermined, sequela
        • T45.615 Adverse effect of thrombolytic drugs
        • T45.615A Adverse effect of thrombolytic drugs, initial encounter
        • T45.615D Adverse effect of thrombolytic drugs, subsequent encounter
        • T45.615S Adverse effect of thrombolytic drugs, sequela
        • T45.616 Underdosing of thrombolytic drugs
        • T45.616A Underdosing of thrombolytic drugs, initial encounter
        • T45.616D Underdosing of thrombolytic drugs, subsequent encounter
        • T45.616S Underdosing of thrombolytic drugs, sequela
        • T45.62 Poisoning by, adverse effect of and underdosing of hemostatic drugs
        • T45.621 Poisoning by hemostatic drug, accidental (unintentional)
        • T45.621A Poisoning by hemostatic drug, accidental (unintentional), initial encounter
        • T45.621D Poisoning by hemostatic drug, accidental (unintentional), subsequent encounter
        • T45.621S Poisoning by hemostatic drug, accidental (unintentional), sequela
        • T45.622 Poisoning by hemostatic drug, intentional self-harm
        • T45.622A Poisoning by hemostatic drug, intentional self-harm, initial encounter
        • T45.622D Poisoning by hemostatic drug, intentional self-harm, subsequent encounter
        • T45.622S Poisoning by hemostatic drug, intentional self-harm, sequela
        • T45.623 Poisoning by hemostatic drug, assault
        • T45.623A Poisoning by hemostatic drug, assault, initial encounter
        • T45.623D Poisoning by hemostatic drug, assault, subsequent encounter
        • T45.623S Poisoning by hemostatic drug, assault, sequela
        • T45.624 Poisoning by hemostatic drug, undetermined
        • T45.624A Poisoning by hemostatic drug, undetermined, initial encounter
        • T45.624D Poisoning by hemostatic drug, undetermined, subsequent encounter
        • T45.624S Poisoning by hemostatic drug, undetermined, sequela
        • T45.625 Adverse effect of hemostatic drug
        • T45.625A Adverse effect of hemostatic drug, initial encounter
        • T45.625D Adverse effect of hemostatic drug, subsequent encounter
        • T45.625S Adverse effect of hemostatic drug, sequela
        • T45.626 Underdosing of hemostatic drugs
        • T45.626A Underdosing of hemostatic drugs, initial encounter
        • T45.626D Underdosing of hemostatic drugs, subsequent encounter
        • T45.626S Underdosing of hemostatic drugs, sequela
        • T45.69 Poisoning by, adverse effect of and underdosing of other fibrinolysis-affecting drugs
        • T45.691 Poisoning by other fibrinolysis-affecting drugs, accidental (unintentional)
        • T45.691A Poisoning by other fibrinolysis-affecting drugs, accidental (unintentional), initial encounter
        • T45.691D Poisoning by other fibrinolysis-affecting drugs, accidental (unintentional), subsequent encounter
        • T45.691S Poisoning by other fibrinolysis-affecting drugs, accidental (unintentional), sequela
        • T45.692 Poisoning by other fibrinolysis-affecting drugs, intentional self-harm
        • T45.692A Poisoning by other fibrinolysis-affecting drugs, intentional self-harm, initial encounter
        • T45.692D Poisoning by other fibrinolysis-affecting drugs, intentional self-harm, subsequent encounter
        • T45.692S Poisoning by other fibrinolysis-affecting drugs, intentional self-harm, sequela
        • T45.693 Poisoning by other fibrinolysis-affecting drugs, assault
        • T45.693A Poisoning by other fibrinolysis-affecting drugs, assault, initial encounter
        • T45.693D Poisoning by other fibrinolysis-affecting drugs, assault, subsequent encounter
        • T45.693S Poisoning by other fibrinolysis-affecting drugs, assault, sequela
        • T45.694 Poisoning by other fibrinolysis-affecting drugs, undetermined
        • T45.694A Poisoning by other fibrinolysis-affecting drugs, undetermined, initial encounter
        • T45.694D Poisoning by other fibrinolysis-affecting drugs, undetermined, subsequent encounter
        • T45.694S Poisoning by other fibrinolysis-affecting drugs, undetermined, sequela
        • T45.695 Adverse effect of other fibrinolysis-affecting drugs
        • T45.695A Adverse effect of other fibrinolysis-affecting drugs, initial encounter
        • T45.695D Adverse effect of other fibrinolysis-affecting drugs, subsequent encounter
        • T45.695S Adverse effect of other fibrinolysis-affecting drugs, sequela
        • T45.696 Underdosing of other fibrinolysis-affecting drugs
        • T45.696A Underdosing of other fibrinolysis-affecting drugs, initial encounter
        • T45.696D Underdosing of other fibrinolysis-affecting drugs, subsequent encounter
        • T45.696S Underdosing of other fibrinolysis-affecting drugs, sequela
        • T45.7 Poisoning by, adverse effect of and underdosing of anticoagulant antagonists, vitamin K and other coagulants
        • T45.7X Poisoning by, adverse effect of and underdosing of anticoagulant antagonists, vitamin K and other coagulants
        • T45.7X1 Poisoning by anticoagulant antagonists, vitamin K and other coagulants, accidental (unintentional)
        • T45.7X1A Poisoning by anticoagulant antagonists, vitamin K and other coagulants, accidental (unintentional), initial encounter
        • T45.7X1D Poisoning by anticoagulant antagonists, vitamin K and other coagulants, accidental (unintentional), subsequent encounter
        • T45.7X1S Poisoning by anticoagulant antagonists, vitamin K and other coagulants, accidental (unintentional), sequela
        • T45.7X2 Poisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm
        • T45.7X2A Poisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm, initial encounter
        • T45.7X2D Poisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm, subsequent encounter
        • T45.7X2S Poisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm, sequela
        • T45.7X3 Poisoning by anticoagulant antagonists, vitamin K and other coagulants, assault
        • T45.7X3A Poisoning by anticoagulant antagonists, vitamin K and other coagulants, assault, initial encounter
        • T45.7X3D Poisoning by anticoagulant antagonists, vitamin K and other coagulants, assault, subsequent encounter
        • T45.7X3S Poisoning by anticoagulant antagonists, vitamin K and other coagulants, assault, sequela
        • T45.7X4 Poisoning by anticoagulant antagonists, vitamin K and other coagulants, undetermined
        • T45.7X4A Poisoning by anticoagulant antagonists, vitamin K and other coagulants, undetermined, initial encounter
        • T45.7X4D Poisoning by anticoagulant antagonists, vitamin K and other coagulants, undetermined, subsequent encounter
        • T45.7X4S Poisoning by anticoagulant antagonists, vitamin K and other coagulants, undetermined, sequela
        • T45.7X5 Adverse effect of anticoagulant antagonists, vitamin K and other coagulants
        • T45.7X5A Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, initial encounter
        • T45.7X5D Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, subsequent encounter
        • T45.7X5S Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, sequela
        • T45.7X6 Underdosing of anticoagulant antagonist, vitamin K and other coagulants
        • T45.7X6A Underdosing of anticoagulant antagonist, vitamin K and other coagulants, initial encounter
        • T45.7X6D Underdosing of anticoagulant antagonist, vitamin K and other coagulants, subsequent encounter
        • T45.7X6S Underdosing of anticoagulant antagonist, vitamin K and other coagulants, sequela
        • T45.8 Poisoning by, adverse effect of and underdosing of other primarily systemic and hematological agents
        • T45.8X Poisoning by, adverse effect of and underdosing of other primarily systemic and hematological agents
        • T45.8X1 Poisoning by other primarily systemic and hematological agents, accidental (unintentional)
        • T45.8X1A Poisoning by other primarily systemic and hematological agents, accidental (unintentional), initial encounter
        • T45.8X1D Poisoning by other primarily systemic and hematological agents, accidental (unintentional), subsequent encounter
        • T45.8X1S Poisoning by other primarily systemic and hematological agents, accidental (unintentional), sequela
        • T45.8X2 Poisoning by other primarily systemic and hematological agents, intentional self-harm
        • T45.8X2A Poisoning by other primarily systemic and hematological agents, intentional self-harm, initial encounter
        • T45.8X2D Poisoning by other primarily systemic and hematological agents, intentional self-harm, subsequent encounter
        • T45.8X2S Poisoning by other primarily systemic and hematological agents, intentional self-harm, sequela
        • T45.8X3 Poisoning by other primarily systemic and hematological agents, assault
        • T45.8X3A Poisoning by other primarily systemic and hematological agents, assault, initial encounter
        • T45.8X3D Poisoning by other primarily systemic and hematological agents, assault, subsequent encounter
        • T45.8X3S Poisoning by other primarily systemic and hematological agents, assault, sequela
        • T45.8X4 Poisoning by other primarily systemic and hematological agents, undetermined
        • T45.8X4A Poisoning by other primarily systemic and hematological agents, undetermined, initial encounter
        • T45.8X4D Poisoning by other primarily systemic and hematological agents, undetermined, subsequent encounter
        • T45.8X4S Poisoning by other primarily systemic and hematological agents, undetermined, sequela
        • T45.8X5 Adverse effect of other primarily systemic and hematological agents
        • T45.8X5A Adverse effect of other primarily systemic and hematological agents, initial encounter
        • T45.8X5D Adverse effect of other primarily systemic and hematological agents, subsequent encounter
        • T45.8X5S Adverse effect of other primarily systemic and hematological agents, sequela
        • T45.8X6 Underdosing of other primarily systemic and hematological agents
        • T45.8X6A Underdosing of other primarily systemic and hematological agents, initial encounter
        • T45.8X6D Underdosing of other primarily systemic and hematological agents, subsequent encounter
        • T45.8X6S Underdosing of other primarily systemic and hematological agents, sequela
        • T45.9 Poisoning by, adverse effect of and underdosing of unspecified primarily systemic and hematological agent
        • T45.91 Poisoning by unspecified primarily systemic and hematological agent, accidental (unintentional)
        • T45.91XA Poisoning by unspecified primarily systemic and hematological agent, accidental (unintentional), initial encounter
        • T45.91XD Poisoning by unspecified primarily systemic and hematological agent, accidental (unintentional), subsequent encounter
        • T45.91XS Poisoning by unspecified primarily systemic and hematological agent, accidental (unintentional), sequela
        • T45.92 Poisoning by unspecified primarily systemic and hematological agent, intentional self-harm
        • T45.92XA Poisoning by unspecified primarily systemic and hematological agent, intentional self-harm, initial encounter
        • T45.92XD Poisoning by unspecified primarily systemic and hematological agent, intentional self-harm, subsequent encounter
        • T45.92XS Poisoning by unspecified primarily systemic and hematological agent, intentional self-harm, sequela
        • T45.93 Poisoning by unspecified primarily systemic and hematological agent, assault
        • T45.93XA Poisoning by unspecified primarily systemic and hematological agent, assault, initial encounter
        • T45.93XD Poisoning by unspecified primarily systemic and hematological agent, assault, subsequent encounter
        • T45.93XS Poisoning by unspecified primarily systemic and hematological agent, assault, sequela
        • T45.94 Poisoning by unspecified primarily systemic and hematological agent, undetermined
        • T45.94XA Poisoning by unspecified primarily systemic and hematological agent, undetermined, initial encounter
        • T45.94XD Poisoning by unspecified primarily systemic and hematological agent, undetermined, subsequent encounter
        • T45.94XS Poisoning by unspecified primarily systemic and hematological agent, undetermined, sequela
        • T45.95 Adverse effect of unspecified primarily systemic and hematological agent
        • T45.95XA Adverse effect of unspecified primarily systemic and hematological agent, initial encounter
        • T45.95XD Adverse effect of unspecified primarily systemic and hematological agent, subsequent encounter
        • T45.95XS Adverse effect of unspecified primarily systemic and hematological agent, sequela
        • T45.96 Underdosing of unspecified primarily systemic and hematological agent
        • T45.96XA Underdosing of unspecified primarily systemic and hematological agent, initial encounter
        • T45.96XD Underdosing of unspecified primarily systemic and hematological agent, subsequent encounter
        • T45.96XS Underdosing of unspecified primarily systemic and hematological agent, sequela